Keywords: bayer, schering, pharma, buys, preclinical, cancer, program

Bayer Schering Pharma buys preclinical cancer program from Nycomed

Article | 11 August 2008

Print This

Germany's Bayer Schering Pharma AG is expanding its oncology pipeline with the acquisition of a preclinical program from Danish drugmaker ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in